We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Patients are the centre and the core of our system. We are professionals committed to quality care and our organizational structure breaks down the traditional boundaries between departments and professional groups, with an exclusive model of knowledge areas.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
Speaker: Dr. Alba Simats Oriol, MSCA postdoctoral researcher at Institute of Biomedical Research at the Spanish Research Council (CSIC),
Abstract: Stroke leads to a significant medical burden, not just from brain injury itself but also due to subsequent secondary complications and comorbidities. By exploring the systemic immunological consequences of stroke, we found that myeloid innate immune memory contributes to secondary peripheral organ dysfunction after stroke. Using single-cell sequencing, we observed persistent pro-inflammatory changes in resident monocytes/macrophages across multiple peripheral organs up to three months after stroke, which were particularly abundant in the heart and associated with the development of chronic cardiac fibrosis and diastolic dysfunction. We identified IL-1b as the key driver of epigenetic changes contributing to innate immune memory post-stroke. By targeting IL-1â or blocking pro-inflammatory monocyte trafficking, we prevented post-stroke cardiac dysfunction, suggesting potential immune-focused therapies. These findings could offer insights into IL-1â-mediated comorbidities and innate immune reprogramming post-stroke, potentially aiding in understanding and preventing stroke-related health complications.
Host: Dr. Anna Rosell Novel, Head of group, Neurovascular Diseases (VHIR)
Register here to attend by Zoom:
https://gencat.zoom.us/webinar/register/WN_H3qMT24iRf6nsjq3YkCjog
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.